Mu et al. showed that BCYRN1 is downregulated in gliomas and controls CUEDC2 expression and the PTEN/AKT/p21 pathway to suppress tumor progression by competitively binding to miR-619-5p [48]. Here, CUEDC2 is linked to neoplasm.